Clinical Trial Update: Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating genotype-tailored treatment for symptomatic acid reflux in children with uncontrolled asthma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Gastroesophageal Reflux Disease

Snippet

Sponsor: Jason Lang, M.D., M.P.H. | Conditions: Asthma, Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2025-09-09